by Mette Bach Dyremose | Dec 20, 2021 | News
In the autumn 2021 Bernadette Mannaerts stepped into ReproUnion’s Executive Board with a passion for drug development and a weak spot for the Nordics. “It has been a pleasure to welcome Bernadette to ReproUnion. With over 35 years in the reproductive medicine...
by Mette Bach Dyremose | Nov 5, 2021 | News
The first week of November marks the European Fertility Week – and this year, for the first time ever, it is shedding light on male infertility issues and men’s health. More than 25 million citizens in the European Union are facing fertility issues today with male...
by Mette Bach Dyremose | Oct 13, 2021 | News
The world’s largest male offspring cohort to examine the fetal origin of adult reproductive function – called the Fetal Programming of Semen Quality (FEPOS) was established in 2017 as part of Katia Keglberg Hærvig’s PhD project, funded by ReproUnion. “We needed the...
by Mette Bach Dyremose | Aug 9, 2021 | News
On the 4th of August Nature published the findings from a global collaboration of scientists, who have identified nearly 300 gene variations that influence reproductive lifespan in women. This can lead to potential new targets for fertility treatments as well as ways...
by Mette Bach Dyremose | Aug 5, 2021 | News
Around 2 percent of all men are not producing sperm cells and would therefore not benefit from fertility treatment to become biological fathers. In collaboration with scientists from 20 Universities around the world, ReproUnion colleagues at Rigshospitalet have now...
by SimonLinden | Jun 29, 2021 | News
In June, the message about the ReproUnion Biobank and Infertility Cohort (RUBIC) spread across Danish, Swedish and scientific media – exactly one year after RUBIC enrolled the first infertile couples! “Today every 10th child is conceived after fertility treatment and...
